This essential fatty acid supplement provides the “good fats” the body needs to help eliminate the “bad fats”. Fit Fats provides Omega 3 essential fatty acids that will better facilitate weight loss and health management. It also helps lower cholesterol and triglyceride levels while improving skin, hair and nail quality. All marine lipids have been screened for metal contaminants.
FIT FATS are particularly effective for people on any kind of hormone therapy,for arthritis sufferers or any person who tends to store excess fat due to chemical complications associated with prescription medications.
In addition to weight loss affects, EFA’s are essential to take daily because
- Increase metabolic rate
- Are part of every cell membrane in the body and are needed for healthy cell repair
- Critical for brain development and health of the nervous system. (The brain is 60-70%
- Assist body to burn more fat and glucose
- Improve skin and hair quality.
- Provide the “good fats” the body needs in order for stored, unwanted body
fat to be eliminated.
- Increase good hormones which helps kidneys eliminate excess salt and water
- Improve immune function
- Effective for people on hormone therapy or medications
- Increase good hormones which help the kidneys rid itself of excess salt and water.
For best results, suggested dosage is 2 gel caps with breakfast and 2 before bed.Do not take on an empty stomach unless eating immediately following.
Fish oil may primarily be indicated to lower triglyceride levels in those with hypertriglyceridemia.Another important indication may be to prevent death in those who have suffered myocardial infarctions. Fish oil is used to decrease clotting tendencies of the blood. It may also be indicated for lowering blood pressure, for preventing restenosis following coronary angioplasty, for alleviating some the symptoms of rheumatoid arthritis and ulcerative colitis and for helping to prevent relapse in Crohn’s disease.
Fish oils, also known as marine oils, are lipids found in fish, particularly cold water fish, and other marine life such as phytoplankton. These oils are rich sources of long-chain polyunsaturated fatty acids of the Omega- 3 type. The two most studied fish oils are the eicosapentaenoic acid (EPA) and the docosahexaenoic acid (DHA).
Supplemental EPA may have anti-inflammatory, antithrombotic and immunomodulatory activities. It may also have triglyceride-lowering activity. EPA may play some therapeutic role in those with cystic fibrosis to reduce disease severity and may similarly play a role in Type 2 diabetes in retarding the progression of diabetic nephropathy.
Supplemental DHA may lower triglyceride levels and in some, may elevate HDL-cholesterol levels. DHA is vital for normal brain development for the fetus and infant and for the maintenance of normal brain function throughout life. Supplemental DHA may have anti-inflammatory and immune-modulating activities.
DHA is indicated to lower triglycerides in some hypertriglyceridemic individuals. It may also be indicated for pregnant women and nursing mothers, for those with peroxisomal disorders, for cystic fibrosis sufferers, for those with attention deficit disorder, dyslexia and, possibly, those with cognitive impairment and dementia (including Alzheimer’s disease).
Omega- 3 plays a key role in a range of vital body processes, from blood pressure and blood clotting to inflammation and immunity. They may be useful for preventing or treating many diseases and disorders. Omega- 3 is also an effective general anti-inflammatory, useful for joint problems, lupus and psoriasis. Studies indicate that people with rheumatoid arthritis experience less joint swelling and stiffness, and may even be able to manage their condition on lower doses of anti-inflammatory drugs when they take fish oil supplements.
Several investigations show that some components of the lipid fraction of the diet, such as Omega – 3 fatty acids, are beneficial with respect to cardiovascular disease and may reduce the risk of incident Alzheimer disease. For example, in a study realized by Dr Lee of the University of Birmingham in 2003 with 11,324 patients, it showed the decrease of the risk of sudden cardiac death as well as reduction in all-cause mortality in the group taking a highly purified form of Omega- 3. Morris and other investigators in 2003 concluded dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimer disease. They studied a total of 815 residents, aged 65 to 94 years, who were initially unaffected by Alzheimer disease.
Harefuah. 2001 Dec;140(12):1156-8, 1230.
J Rheumatol. 2000 Oct;27(10):2343-6.
Cardiovascular disease (CVD) is associated with dyslipidemia and frequently with insulin resistance, both of which are, in general, not alleviated by antilipidemic drugs. Our objective was to examine whether a dietary supplement containing omega-3 fatty acids (n-3 FA) can reduce the levels of serum lipids, fasting insulin and glucose in documented CVD patients treated by statins or bezafibrates. In a double-blind placebo-controlled trial of parallel design, 52 patients, age 69.2 years +/- 3.6 treated by antilipidemic drugs, were randomly assigned to receive daily 7 gr of a dietary concentrated supplement containing 67% n-3 FA (185 mg EPA and 465 mg/g DHA) in a form of spread (Yamega Ltd, Israel) or olive oil spread (placebo) and recommended to reduce the consumption of omega-6 fatty acids for 12 weeks. The average values +/- SD before and after dietary supplementations were compared. RESULTS: 44 patients (23 in the n-3 FA group) completed the study. In the n-3FA group we observed a significant decrease (p < 0.05) of total cholesterol (12.2%). LDL-cholesterol (16.8%), triglycerides (36.1%), insulin in hyperinsulinemic subjects (> 20 microunits/ml)(34.9%), and no significant changes in HDL-cholesterol and glucose. No hyperglycemia was detected. In the olive oil group we observed a significant decrease (p <0.05) in the LDL-cholesterol values of 15.5% and no significant changes in the other parameters. No side effects were reported during the study in any of the participants. Our findings demonstrate that the incorporation of the dietary supplement containing EPA and DHA omega-3 fatty acids reduces significantly the above risk factors forCVD.
Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis.
Discipline of Nutrition and Dietetics, Faculty of Medicine and Health Sciences,and the Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Callaghan, NSW, Australia.
To determine the efficacy of fish oil derived (n-3) fatty acid supplementation (3-6 capsules/day) in subjects with rheumatoid arthritis (RA) whose (n-6) fatty acid
intake in the background diet was < 10 g/day, compared to olive/corn oil capsule supplement over a 15 week period. METHODS: A placebo controlled, double blind, randomized 15 week study to determine the effect of supplementation on clinical variables in 50 subjects with RA whose background diet was naturally low in (n-6) fatty acids. Fish oil containing 60% (n-3) fatty acids was supplemented at a rate of 40 mg/kg body weight. RESULTS: Analysis of 9 clinical variables indicated there was a significant difference (p < 0.02) between control and treatment groups. Five subjects in the treatment group and 3 in the control group met the American College of Rheumatology 20% improvement criteria. Dietary supplementation resulted in a significant increase in eicosapentaenoic acid in plasma and monocyte lipids in the supplemented group.
The findings suggest that fish oil supplementation that delivers (n-3) fatty acids at a dose of 40 mg/kg body weight/day, with dietary (n-6) fatty acid intake < 10 g/day in the background diet, results in substantial cellular incorporation of(n-3) fatty acids and improvements in clinical status in patients with RA.
Review with your doctor. If you are taking medications or have a medical condition,consult a physician before using this or any nutritional supplement product.